Two Sigma Investments’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.2M Buy
45,700
+18,500
+68% +$4.31M 0.01% 1334
2025
Q4
$5.63M Sell
27,200
-9,800
-26% -$1.94M 0.01% 1605
2025
Q3
$6.86M Buy
+37,000
New +$6.34M 0.01% 1211
2022
Q1
Sell
-139,200
Closed -$23.8M 3491
2021
Q4
$23.8M Buy
139,200
+134,200
+2,684% +$22M 0.05% 419
2021
Q3
$808K Sell
5,000
-119,900
-96% -$20.5M ﹤0.01% 2812
2021
Q2
$20.6M Buy
124,900
+45,800
+58% +$7.58M 0.05% 485
2021
Q1
$13M Buy
+79,100
New +$12.8M 0.03% 599
2020
Q4
Sell
-10,400
Closed -$1.55M 3552
2020
Q3
$1.55M Sell
10,400
-59,500
-85% -$8.8M 0.01% 1463
2020
Q2
$9.83M Buy
+69,900
New +$10.2M 0.05% 395
2020
Q1
Sell
-79,600
Closed -$11.6M 3480
2019
Q4
$11.6M Sell
79,600
-151,000
-65% -$20.5M 0.03% 558
2019
Q3
$29.8M Buy
230,600
+216,600
+1,547% +$28.5M 0.1% 262
2019
Q2
$1.95M Sell
14,000
-81,800
-85% -$11.3M 0.01% 1458
2019
Q1
$13.4M Buy
95,800
+37,500
+64% +$5.02M 0.04% 545
2018
Q4
$7.52M Sell
58,300
-46,900
-45% -$6.54M 0.03% 631
2018
Q3
$14.5M Sell
105,200
-187,400
-64% -$24.9M 0.04% 511
2018
Q2
$35.5M Buy
292,600
+111,800
+62% +$13.9M 0.11% 250
2018
Q1
$23.2M Buy
180,800
+142,200
+368% +$19.2M 0.08% 309
2017
Q4
$5.39M Buy
38,600
+13,600
+54% +$1.89M 0.02% 862
2017
Q3
$3.25M Buy
25,000
+12,000
+92% +$1.59M 0.01% 1027
2017
Q2
$1.72M Sell
13,000
-94,300
-88% -$12M 0.01% 1527
2017
Q1
$13.4M Buy
107,300
+72,000
+204% +$8.6M 0.05% 509
2016
Q4
$4.07M Sell
35,300
-82,500
-70% -$9.53M 0.02% 962
2016
Q3
$13.9M Sell
117,800
-5,800
-5% -$704K 0.05% 424
2016
Q2
$15M Sell
123,600
-15,400
-11% -$1.75M 0.06% 361
2016
Q1
$15M Buy
139,000
+97,000
+231% +$10M 0.07% 331
2015
Q4
$4.31M Sell
42,000
-40,000
-49% -$4.02M 0.02% 716
2015
Q3
$7.66M Buy
82,000
+19,000
+30% +$1.84M 0.04% 415
2015
Q2
$6.14M Buy
63,000
+15,000
+31% +$1.5M 0.03% 625
2015
Q1
$4.83M Buy
+48,000
New +$4.88M 0.02% 732

Other funds holding JNJ

Two Sigma Investments's JNJ Position: Q1 2026 in Review

Two Sigma Investments increased its Johnson & Johnson (JNJ) stake by 75% in Q1 2026, buying an estimated $5.33M and bringing the position to 53,253 shares worth $13M. The position accounts for 0.01% of the portfolio, ranked #1234.

Two Sigma Investments first reported a position in JNJ in Q3 2013 and has held it in 46 quarters since. The position peaked at $269M in Q1 2021. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Two Sigma Investments held 53,253 shares of Johnson & Johnson worth $13M as of Q1 2026.
  • Two Sigma Investments bought 22,894 Johnson & Johnson shares in Q1 2026, an estimated $5.33M.
  • Johnson & Johnson made up 0.01% of Two Sigma Investments's portfolio in Q1 2026, its #1234 holding.
  • Two Sigma Investments first reported a position in Johnson & Johnson in Q3 2013 and has held it in 46 quarters since.
  • Two Sigma Investments's Johnson & Johnson position peaked at $269M in Q1 2021.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.